Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesothelioma
Scientists have developed a drug to treat mesothelioma, a notoriously hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.
Thousands of people are diagnosed with the disease globally every year, which tends to develop in the lungs and is mainly caused by exposure to asbestos at work. It is aggressive and deadly, and has one of the world’s worst cancer survival rates.
About Author
More Stories
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Trump extends deadline for TikTok sale to non-Chinese buyer to avoid ban
Genetic data is an another asset to be exploited – beware who has yours | John Naughton